Comparison of Hemodynamic Response between Patients with Systolic Heart Failure Differing in Serum Aldosterone Concentrations during and after a 6-Minute Walk Test

Aldosterone regulates hemodynamics, including blood pressure (BP), and is involved in the development and progression of cardiovascular diseases, including systolic heart failure (HF). While exercise intolerance is typical for HF, neither BP nor heart rate (HR) have specific characteristics in HF patients. This study compares BP and HR profiles during and after standardized exercise between patients with systolic HF with either lower or higher aldosterone concentrations. We measured BP and HR in 306 ambulatory adults with systolic HF (left ventricular ejection fraction (LVEF) <50%) during and after a 6 min walk test (6MWT). All patients underwent a resting transthoracic echocardiography, and venous blood samples were collected for biochemical analyses. The patients were also divided into tertiles of serum aldosterone concentration: T1 (<106 pg/mL), T2 (106 and 263 pg/mL) and T3 (>263 pg/mL), respectively. Individuals from T1 and T2 were combined into T1–T2 as the reference group for comparisons with patients from T3. The individuals from T3 had significantly lower systolic, mean and diastolic BPs at rest, at the end and at 1 and 3 min post-6MWT recovery, as well as a more dilated left atrium and right ventricle alongside a higher concentration of N-terminal pro-B-type natriuretic peptide (NT-proBNP). Higher serum aldosterone concentration in HF patients with an LVEF < 50% is associated with a lower 6MWT BP but not an HR profile.

[1]  P. Guzik,et al.  Publication ethics of human studies in the light of the Declaration of Helsinki – a mini-review , 2022, Journal of Medical Science.

[2]  J. Božić,et al.  Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers , 2020, World journal of cardiology.

[3]  P. Ponikowski,et al.  Heart rate and blood pressure monitoring in heart failure , 2019, European heart journal supplements : journal of the European Society of Cardiology.

[4]  P. Ponikowski,et al.  Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology , 2019, European journal of heart failure.

[5]  A. Kotsia,et al.  6-minute walking test: a useful tool in the management of heart failure patients , 2019, Therapeutic advances in cardiovascular disease.

[6]  G. Reed,et al.  Renin Activity in Heart Failure with Reduced Systolic Function—New Insights , 2019, International journal of molecular sciences.

[7]  Bruce D. Johnson,et al.  Skeletal Muscle Fatigability in Heart Failure , 2019, Front. Physiol..

[8]  R. Britto,et al.  Safety of early performance of the six-minute walk test following acute myocardial infarction: a cross-sectional study , 2017, Brazilian journal of physical therapy.

[9]  T. Marwick,et al.  Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction. , 2016, Journal of the American College of Cardiology.

[10]  A. Jegier,et al.  Blood Pressure Response to Submaximal Exercise Test in Adults , 2016, BioMed research international.

[11]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[12]  A. Wykrętowicz,et al.  Prospective observational study on predicting adverse clinical outcomes in patients with implanted defibrillating devices – a study rationale, design and principal methods , 2016 .

[13]  Piotr Ponikowski,et al.  The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction. , 2015, European heart journal.

[14]  T. Kulik Pulmonary Hypertension Caused by Pulmonary Venous Hypertension , 2014, Pulmonary circulation.

[15]  A. Coats,et al.  The 'skeletal muscle hypothesis in heart failure' revised. , 2013, European heart journal.

[16]  M. Hori,et al.  Heart rate as a target of treatment of chronic heart failure. , 2012, Journal of cardiology.

[17]  A. Durante,et al.  Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis. , 2012, Current pharmaceutical design.

[18]  W. Chan,et al.  Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. , 2011, American heart journal.

[19]  H. Inoue,et al.  Renal insufficiency coexisting with heart failure is related to elevated sympathetic nerve activity , 2010, Autonomic Neuroscience.

[20]  Arturo Evangelista,et al.  European Association of Echocardiography recommendations for training, competence, and quality improvement in echocardiography. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[21]  Javed Butler,et al.  The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. , 2009, Journal of the American College of Cardiology.

[22]  K. Dimopoulos,et al.  Cardiovascular and ventilatory control during exercise in chronic heart failure: role of muscle reflexes. , 2008, International journal of cardiology.

[23]  Nancy M Albert,et al.  Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. , 2006, JAMA.

[24]  A. Hinz,et al.  Acute Effects of Aldosterone on the Autonomic Nervous System and the Baroreflex Function in Healthy Humans , 2006, Journal of neuroendocrinology.

[25]  David J Cohen,et al.  The association between blood pressure and mortality in patients with heart failure. , 2006, American heart journal.

[26]  Luigi Tavazzi,et al.  Acute Heart Failure Syndromes: Current State and Framework for Future Research , 2005, Circulation.

[27]  ATS Statement , 2002 .

[28]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[29]  P. Ponikowski,et al.  Enhanced Ventilatory Response to Exercise in Patients With Chronic Heart Failure and Preserved Exercise Tolerance: Marker of Abnormal Cardiorespiratory Reflex Control and Predictor of Poor Prognosis , 2001, Circulation.

[30]  A. Struthers,et al.  Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. , 1997, Cardiovascular research.

[31]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[32]  T. Thrasher Baroreceptor Regulation of Vasopressin and Renin Secretion: Low-Pressure versus High-Pressure Receptors , 1994, Frontiers in Neuroendocrinology.

[33]  S. Adamopoulos,et al.  Controlled Trial of Physical Training in Chronic Heart Failure: Exercise Performance, Hemodynamics, Ventilation, and Autonomic Function , 1992, Circulation.